Medication for Eosinophilic Esophagitis
For eosinophilic esophagitis, initiate treatment with either a proton pump inhibitor (PPI) twice daily or topical corticosteroids, as both are equally effective first-line options with strong guideline support. 1
First-Line Treatment Options
You have three evidence-based choices for initial therapy:
1. Proton Pump Inhibitors (Preferred for ease of use)
- Dose: Omeprazole 20 mg twice daily (or equivalent PPI at double standard dose)
- Duration: 8-12 weeks before assessing response with repeat endoscopy and biopsies 1
- Efficacy: Achieves histological remission in approximately 50% of patients and clinical response in 71% 1, 2
- Mechanism: Anti-inflammatory effects independent of acid suppression 2
Key advantage: PPIs are accessible, low-cost, safe, and most commonly prescribed in real-world practice despite being off-label for EoE 2. The twice-daily dosing is critical—once-daily dosing is less effective 1.
2. Topical Corticosteroids (Highest quality evidence)
- Evidence grade: HIGH for inducing histological and clinical remission 1
- Options: Swallowed budesonide or fluticasone formulations designed to coat the esophageal mucosa
- Efficacy: More effective than PPIs in head-to-head comparisons, particularly for advanced disease 2
Critical caveat: Relapse rates are high after withdrawal, so maintenance therapy is strongly recommended 1
3. Elimination Diets
- Empiric elimination diets (2-food, 4-food, or 6-food) are effective alternatives
- Requires: Experienced dietitian support throughout elimination and reintroduction 1
- Do NOT use: Allergy testing (skin prick, IgE, patch testing) to guide food choices—it's not recommended 1
Treatment Algorithm
Step 1: Choose PPI or topical steroid based on:
- PPI first if: Patient preference for oral medication, cost concerns, or inflammatory phenotype
- Topical steroid first if: Severe disease, fibrostenotic features, or PPI failure anticipated
Step 2: Treat for 8-12 weeks, then repeat endoscopy with biopsies to assess histological response 1
Step 3: If response achieved, continue maintenance therapy indefinitely with the same agent:
- PPIs can often be reduced to standard once-daily dosing for maintenance 1
- Topical steroids require ongoing treatment to prevent relapse 1
Step 4: If no response after 8-12 weeks:
- Switch to the alternative first-line agent (PPI ↔ topical steroid)
- Consider combining dietary therapy with pharmacological treatment 1
- Refer to gastroenterology/allergy for refractory cases 1
Additional Management Considerations
For Strictures or Dysphagia Despite Medical Therapy
- Endoscopic dilation is safe and effective for fibrostenotic disease 1
- Combine dilation with anti-inflammatory therapy (topical steroids preferred) for best outcomes 1
- Medical treatment with topical steroids reduces future stricture development 1
Medications to AVOID
- Do NOT use: Immunomodulators (azathioprine, 6-mercaptopurine), anti-TNF agents, anti-integrin therapies, sodium cromoglycate, montelukast, or antihistamines for EoE treatment 1
- These have no role in EoE management (though antihistamines/montelukast may help concomitant atopic disease)
Common Pitfalls
- Underdosing PPIs: Must use twice-daily dosing for induction; once-daily is insufficient 1
- Stopping treatment after initial response: EoE requires long-term maintenance therapy—discontinuation leads to relapse 1
- Using allergy testing to guide diet: This approach is ineffective; use empiric elimination instead 1
- Treating symptoms alone: Always confirm histological response with repeat endoscopy—symptom improvement doesn't guarantee mucosal healing 1
- Confusing with GERD: EoE and GERD can coexist but are distinct entities requiring different treatment approaches 1